Leaving sleep apnea untreated raises your risk of heart failure by 140%, stroke by 60%, and coronary heart disease by 30%. Those numbers come from the Sleep Heart Health Study, one of the largest investigations into the condition, which tracked over 6,400 people. Beyond the heart, untreated sleep apnea quietly damages your metabolism, your mental health, your liver, and your ability to think clearly, all while you assume you’re just a loud snorer.
An estimated 80% of people with moderate-to-severe sleep apnea remain undiagnosed. That means most of the damage described below is happening to people who don’t yet know they have the condition.
Heart Disease and Stroke Risk
Every time your airway collapses during sleep, your blood oxygen drops and your body triggers a stress response. Your heart rate spikes, your blood pressure surges, and inflammatory processes activate throughout your cardiovascular system. This happens dozens or even hundreds of times per night in severe cases, and the cumulative toll is substantial.
The 140% increase in heart failure risk is the most dramatic cardiovascular consequence, but the 60% increase in stroke risk is arguably more dangerous because strokes can strike without warning. The 30% bump in coronary heart disease risk means the arteries feeding your heart are more likely to narrow and harden over time. High blood pressure, which is both a cause and a consequence of sleep apnea, tends to resist standard medication when apnea goes untreated. If your blood pressure isn’t responding well to treatment, undiagnosed sleep apnea is one of the first things worth investigating.
Blood Sugar and Type 2 Diabetes
When your oxygen levels repeatedly drop and recover throughout the night, it does something specific to how your body handles sugar: it makes your cells less responsive to insulin. This has been demonstrated in both animal and human studies. Even healthy volunteers exposed to just five hours of intermittent low oxygen during wakefulness showed measurable drops in insulin sensitivity.
A study of 4,400 middle-aged participants confirmed that repeated nighttime oxygen drops were an independent risk factor for developing type 2 diabetes over a three-year follow-up. The mechanism involves increased oxidative stress and inflammatory signaling triggered by the oxygen swings. If you already have prediabetes or type 2 diabetes, untreated sleep apnea makes blood sugar harder to control, creating a cycle where each condition worsens the other.
Depression and Anxiety
About 35% of people with newly diagnosed, untreated sleep apnea meet the criteria for depression, and nearly 44% have clinically significant anxiety. Those rates are far higher than the general population. Women appear to be hit harder: one large U.S. study of nearly 10,000 patients found that women with sleep apnea were 5.2 times more likely to have depression compared to women without it, while men were 2.4 times more likely.
The connection makes biological sense. Fragmented sleep disrupts the brain’s ability to regulate mood. But the practical problem is that many people get treated for depression or anxiety without anyone checking whether sleep apnea is fueling those symptoms. Treating the apnea doesn’t guarantee the depression lifts, but it removes a major contributor.
Thinking, Memory, and Daily Function
Chronic sleep fragmentation impairs the brain’s executive functions: the mental skills you use for planning, problem-solving, impulse control, and holding information in working memory. People with untreated apnea often describe brain fog, difficulty concentrating at work, or forgetting things they normally wouldn’t. The repeated oxygen drops are thought to cause small vessel injuries in the brain, though the exact relationship between apnea and structural brain changes is still being studied, with age playing a significant confounding role.
The cognitive effects are not subtle in daily life. Drivers with sleep apnea face a meaningfully higher crash risk, with studies placing the increase somewhere between 1.2 and nearly 5 times the normal rate depending on severity. Daytime sleepiness is the obvious culprit, but slowed reaction time and impaired attention also play roles. This is one of the most immediate, practical dangers of untreated apnea.
Liver Damage
Untreated sleep apnea is closely linked to non-alcoholic fatty liver disease, a condition where fat builds up in the liver and can eventually lead to inflammation and scarring. The connection runs through the same metabolic pathways: intermittent oxygen drops increase insulin resistance, which promotes fat storage in liver cells. Research now identifies sleep apnea and its associated oxygen drops as independent risk factors for fatty liver disease, meaning apnea contributes to liver damage even after accounting for obesity and other shared risk factors.
Surgical Complications
If you need surgery and your sleep apnea is untreated, your risk of complications goes up significantly. A study comparing treated and untreated apnea patients undergoing general or vascular surgery found that the untreated group had a cardiopulmonary complication rate of 6.7%, compared to 4.0% in the treated group. More concerning, untreated patients were 2.5 times more likely to need emergency reintubation after surgery and 2.6 times more likely to have a heart attack in the postoperative period. Anesthesia relaxes the airway muscles even further, and pain medications can suppress breathing drive, making an already compromised airway more dangerous.
Effects on Children
Sleep apnea isn’t just an adult condition. In children, the consequences look different and can be mistaken for other problems. Kids with untreated apnea often develop attention problems, hyperactivity, and irritability that closely mimic ADHD. Many are diagnosed with attention-deficit/hyperactivity disorder when sleep-disordered breathing is the actual root cause or a major contributor.
The academic impact is measurable. Children with untreated apnea show impairments in reading comprehension, math skills, problem-solving, and memory. Their executive function, the set of mental skills needed to plan and organize, is broadly compromised. Growth can also be affected: studies have found that children with sleep apnea produce less growth hormone, and treating the apnea (typically by removing enlarged tonsils and adenoids) leads to improved growth, particularly in weight, along with recovery of normal growth hormone levels.
Overall Mortality Risk
The most sobering data concerns death. Two major long-term studies have examined all-cause mortality in people with untreated apnea. An Australian cohort found that moderate-to-severe untreated apnea carried a hazard ratio between 4.4 and 6.2, meaning those individuals were roughly four to six times more likely to die during the study period after adjusting for other health factors. The Wisconsin Sleep Cohort found a hazard ratio of 2.7 to 3.8 for severe cases, depending on how the data were analyzed. Both studies confirmed that the mortality risk was concentrated in people with severe, untreated disease.
These numbers don’t mean sleep apnea directly kills most people who have it. They reflect the accumulated burden of cardiovascular disease, metabolic dysfunction, and other complications that compound over years of disrupted sleep and oxygen deprivation. The gap between treated and untreated outcomes is what makes these findings actionable: treatment substantially narrows that risk.

